Audiologists in Rancho Cordova, CA Accepting Medicare
6 Audiologists found. Showing 1 - 6
 Cchat Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11100 Coloma Rd, Rancho Cordova, CA 95670 Phone: 916-361-7290 |
 Dr. Elizabeth R Marwaha, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11100 Coloma Rd, Rancho Cordova, CA 95670 Phone: 916-361-7290 |
Laura Jean Covello, M.A., CCC-A, M.ED. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11100 Coloma Rd, Rancho Cordova, CA 95670 Phone: 916-361-7290 Fax: 916-361-8613 |
Mrs. Lea M Lowrie, M.S. Audiologist Medicare: Medicare Enrolled Practice Location: 10725 International Dr, Rancho Cordova, CA 95670 Phone: 916-631-2141 |
Cchat Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11100 Coloma Rd, Cchat Center, Rancho Cordova, CA 95670 Phone: 916-361-7290 Fax: 916-361-8613 |
Dr. Katherine Louise Isbell, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11100 Coloma Rd, Rancho Cordova, CA 95670 Phone: 916-361-7290 |
News Archive
Helmholtz Association grant for research on diseases caused by protein misfolding
Professor Erich Wanker of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and of the Excellence Cluster Neurocure is to receive EUR 675 000 in funding from the Helmholtz Association over the next two years. The grant shall be used to accelerate the search for active agents to treat diseases that are caused by protein misfolding. These include Alzheimer's and Parkinson's.
Drug used to control Type II diabetes can help repair spinal cords of mice suffering from inherited disease
A drug used to control Type II diabetes can help repair the spinal cords of mice suffering from the inherited disease adrenoleukodystrophy which, untreated, leads eventually to a paralysis, a vegetative state and death.
Ipsen receives approval from FDA for new device designed to deliver Somatuline Depot Injection
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Researchers identify biomarker that could predict disease severity in glaucoma patients
Glaucoma, a leading cause of blindness worldwide, most often is diagnosed during a routine eye exam. Over time, elevated pressure inside the eye damages the optic nerve, leading to vision loss. Unfortunately, there's no way to accurately predict which patients might lose vision most rapidly.
Arena reports lower net loss of $28.80M for second-quarter 2010
Arena Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2010, and recent developments, including the successful Pre-Approval Inspection, or PAI, of the company's Swiss drug product manufacturing facility by the US Food and Drug Administration, or FDA.
› Verified 9 days ago
Physical Therapists
Optometrists
Speech-Language Pathologists
Chiropractors
Audiologists
Occupational Therapists
Podiatrists